BIO-key International Files 8-K Report
Ticker: BKYI · Form: 8-K · Filed: Jun 17, 2024 · CIK: 1019034
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: BK
TL;DR
BIO-key International (BK) filed an 8-K on June 17, 2024, updating its financial and operational status.
AI Summary
On June 17, 2024, BIO-key International, Inc. filed an 8-K report detailing its financial results and exhibits. The company, incorporated in Delaware, is headquartered in Holmdel, NJ, and operates in the prepackaged software industry. This filing serves as a current report under the Securities Exchange Act of 1934.
Why It Matters
This 8-K filing provides an official update on BIO-key International's financial condition and operations, which is crucial information for investors and stakeholders to assess the company's performance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not contain any immediately apparent negative or positive material events.
Key Players & Entities
- BIO-key International, Inc. (company) — Registrant
- June 17, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Holmdel, NJ (location) — Principal Executive Offices
- 732-359-1100 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for BIO-key International, Inc.?
The primary purpose is to report on the company's Results of Operations and Financial Condition, as well as to file Financial Statements and Exhibits.
When was BIO-key International, Inc. incorporated?
BIO-key International, Inc. was incorporated in Delaware.
What is the business address of BIO-key International, Inc.?
The business address is 101 Crawfords Corner Road, Suite 4116, Holmdel, NJ 07733.
What is the SIC code for BIO-key International, Inc.?
The Standard Industrial Classification (SIC) code is 7372, which falls under SERVICES-PREPACKAGED SOFTWARE.
What is the fiscal year end for BIO-key International, Inc.?
The fiscal year end for BIO-key International, Inc. is December 31st.
Filing Stats: 518 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-06-17 16:17:51
Filing Documents
- bkyi20240617_8k.htm (8-K) — 28KB
- ex_689045.htm (EX-99.1) — 211KB
- biokey.jpg (GRAPHIC) — 6KB
- 0001437749-24-020489.txt ( ) — 394KB
- bkyi-20240617.xsd (EX-101.SCH) — 3KB
- bkyi-20240617_def.xml (EX-101.DEF) — 11KB
- bkyi-20240617_lab.xml (EX-101.LAB) — 15KB
- bkyi-20240617_pre.xml (EX-101.PRE) — 11KB
- bkyi20240617_8k_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On June 17, 2024 BIO-key International, Inc. (the "Company") issued a press release announcing its financial results for its first quarter of fiscal year 2024. A copy of the press release issued by the Company on June 17, 2024 is attached as Exhibit 99. The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
01. Financial Statements, Pro Forma Financial Information and Exhibit
Item 9.01. Financial Statements, Pro Forma Financial Information and Exhibit. (d) Exhibits. The following exhibit is furnished herewith: 99.1 Press Release, dated June 17, 2024 issued by the Company. 104 Cover Page Interactive Data File (embedded with the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-KEY INTERNATIONAL, INC. Date: June 17, 2024 By: /s/ Cecilia C. Welch Cecilia C. Welch Chief Financial Officer EXHIBIT INDEX Exhibit No. Description 99.1 Press Release, dated June 17, 2024 issued by the Company.